Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Treasury Shares: 2011-2025

Historic Treasury Shares for Cross Country Healthcare (CCRN) over the last 15 years, with Q3 2025 value amounting to $293178.0.

  • Cross Country Healthcare's Treasury Shares fell 4678.27% to $293178.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $293178.0, marking a year-over-year decrease of 4678.27%. This contributed to the annual value of $538589.0 for FY2024, which is 163.37% down from last year.
  • According to the latest figures from Q3 2025, Cross Country Healthcare's Treasury Shares is $293178.0, which was down 4678.27% from $297111.0 recorded in Q2 2025.
  • Cross Country Healthcare's Treasury Shares' 5-year high stood at $1.2 million during Q1 2021, with a 5-year trough of $293178.0 in Q3 2025.
  • Its 5-year average for Treasury Shares is $661906.6, with a median of $584714.0 in 2024.
  • In the last 5 years, Cross Country Healthcare's Treasury Shares dropped by 13.68% in 2024 and then tumbled by 4735.94% in 2025.
  • Quarter analysis of 5 years shows Cross Country Healthcare's Treasury Shares stood at $1.0 million in 2021, then crashed by 35.11% to $674508.0 in 2022, then dropped by 18.82% to $547534.0 in 2023, then decreased by 1.63% to $538589.0 in 2024, then crashed by 45.57% to $293178.0 in 2025.
  • Its Treasury Shares was $293178.0 in Q3 2025, compared to $297111.0 in Q2 2025 and $308615.0 in Q1 2025.